Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Under the Spotlight: Agentic AI
In an interview with Pharmaceutical Outsourcing, ArisGlobal’s Jason Bryant discusses the premise of AI’s next high-profile incarnation, the technology’s potential in late-stage pharma R&D operations, emerging early use cases, and some of the guardrails that need to be in place to ensure trusted, impactful use. read more
Executive Q&A - Early Drug Development
In this Q&A, we explore early-stage pharmaceutical drug development trends, key scientific and technical challenges, and the role emerging technologies play in enhancing efficiency and quality during early pharmaceutical development. read more
An Interview With Christoph van Eickels, Dr. Deepak Venkanna, and Holly Olmstead
Executive Q&A topic: Regulatory Requirements for Upstream Bioprocess Solutions read more
Quality: The Gold Standard for CDMOs - No Exceptions, No Compromises
In today’s hyper-competitive pharmaceutical landscape, innovation, speed-to-market and cost control usually take the spotlight when selecting a contract development and manufacturing organization (CDMO). However, underneath all those metrics, a single truth remains: if quality fails, so does everything else. read more

View More Editorial Articles »

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

View More Videos »

View More Whitepapers & Application Notes »

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Tuesday, April 07, 2026
Azenta announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this role, Mr. Martin will lead ... read more
Perceptive Discovery Expands In Vitro Capabilities at Needham, MA Site to Accelerate Preclinical Oncology Research
Friday, April 03, 2026
Perceptive Discovery announced a major expansion of its in vitro laboratory capabilities at its Needham, Massachusetts facility. This strategic ... read more
Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimization
Thursday, April 02, 2026
Lonza announced the launch of its Media Development Lab at its Singapore site. The offering aims to support bioprocessing customers in optimizing ... read more
CellCarta and Pillar Biosciences Announce Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials
Thursday, April 02, 2026
CellCarta and Pillar Biosciences announced a global multi-year strategic partnership to broaden access to fast, operationally streamlined next-... read more
Adragos Pharma Finalize the Acquisition of Commercial-Scale, Sterile Fill-Finish Manufacturing Site at Maisons-Alfort, France, from Sanofi
Wednesday, April 01, 2026
Adragos Pharma announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi. read more

View More News »

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Tuesday, April 07, 2026
Perceptive Discovery Expands In Vitro Capabilities at Needham, MA Site to Accelerate Preclinical Oncology Research
Friday, April 03, 2026
Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimization
Thursday, April 02, 2026

Jan/Feb/Mar 2026

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

INTERPHEX 2026
Tuesday, April 21, 2026
2026 AAPS National Biotechnology Conference
Monday, May 11, 2026
Investigative & Preclinical Toxicology Summit 2026
Tuesday, May 12, 2026

View More Events »

2026 Company Focus & Industry Reference Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary magazine subscription